A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors

NCT07016490 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: SSGJ-709

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.

Collaborators

[object Object]